The closing price of 4D Molecular Therapeutics Inc (NASDAQ: FDMT) was $30.01 for the day, down -5.81% from the previous closing price of $31.86. In other words, the price has decreased by -$1.85 from its previous closing price. On the day, 1069995 shares were traded.
Ratios:
Our analysis of FDMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 18.07 and its Current Ratio is at 18.07. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On October 26, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $25.
On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $32.Cantor Fitzgerald initiated its Overweight rating on October 24, 2023, with a $32 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 27 ’24 when Bizily Scott sold 5,833 shares for $35.04 per share. The transaction valued at 204,410 led to the insider holds 1,737 shares of the business.
Bizily Scott sold 1,750 shares of FDMT for $54,722 on Mar 18 ’24. The Chief Legal Officer now owns 1,737 shares after completing the transaction at $31.27 per share. On Feb 27 ’24, another insider, Bizily Scott, who serves as the Chief Legal Officer of the company, sold 1,909 shares for $30.00 each. As a result, the insider received 57,270 and left with 1,737 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FDMT now has a Market Capitalization of 1.50B and an Enterprise Value of 1.22B. For the stock, the TTM Price-to-Sale (P/S) ratio is 67.94 while its Price-to-Book (P/B) ratio in mrq is 3.89. Its current Enterprise Value per Revenue stands at 58.98 whereas that against EBITDA is -11.41.
Stock Price History:
Over the past 52 weeks, FDMT has reached a high of $36.25, while it has fallen to a 52-week low of $9.44. The 50-Day Moving Average of the stock is 27.60, while the 200-Day Moving Average is calculated to be 18.53.
Shares Statistics:
FDMT traded an average of 1.16M shares per day over the past three months and 708.44k shares per day over the past ten days. A total of 49.78M shares are outstanding, with a floating share count of 43.59M. Insiders hold about 12.43% of the company’s shares, while institutions hold 74.93% stake in the company. Shares short for FDMT as of Mar 15, 2024 were 8.5M with a Short Ratio of 7.36, compared to 7.06M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 17.08% and a Short% of Float of 21.34%.
Earnings Estimates
The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.72 for the current quarter, with a high estimate of -$0.68 and a low estimate of -$0.73, while EPS last year was -$0.88. The consensus estimate for the next quarter is -$0.73, with high estimates of -$0.7 and low estimates of -$0.75.
Analysts are recommending an EPS of between -$2.89 and -$3.25 for the fiscal current year, implying an average EPS of -$3.03. EPS for the following year is -$3.82, with 5 analysts recommending between -$3.26 and -$4.5.
